Gland Pharma indexed at Rs. 1,710 at the NSE, a 14% top class to the issue fee of Rs. 1,500 apiece while oon the BSE, the shares opened at Rs 1,701, a thirteen.4 premium over its trouble charge.
The stock become indexed at Rs 1701, a top class of thirteen.Four% to the initial public offer (IPO) price.
The pharma agency’s initial public offer (IPO), which closed on November eleven, become subscribed times.
The enterprise’s Rs. 6,479.Five-crore initial share-sale received bids for six,21,55,670 shares as in opposition to three,02,37,879 stocks on offer, translating into 2.06 times subscription.
Gland Pharma is one in all the largest and quickest developing injectable targeted B2B business enterprise. The problem price turned into fixed at Rs. 1,500 in line with share.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
